1. Home
  2. ARTL vs SBLX Comparison

ARTL vs SBLX Comparison

Compare ARTL & SBLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.31

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

SBLX

StableX Technologies Inc.

HOLD

Current Price

$2.29

Market Cap

3.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTL
SBLX
Founded
2011
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARTL
SBLX
Price
$1.31
$2.29
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
28.9K
114.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$2.11
52 Week High
$28.60
$7.85

Technical Indicators

Market Signals
Indicator
ARTL
SBLX
Relative Strength Index (RSI) 40.83 34.57
Support Level $0.90 N/A
Resistance Level $1.85 $4.00
Average True Range (ATR) 0.14 0.26
MACD -0.01 -0.01
Stochastic Oscillator 34.78 20.73

Price Performance

Historical Comparison
ARTL
SBLX

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About SBLX StableX Technologies Inc.

StableX Technologies Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.

Share on Social Networks: